sorry blueturtle, did misquote you, meant 'story' not 'stock' Always encouraged by your knowledge and enthusiasm in avanco - and even more so when you are holding
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%